Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia

Eliana Gotti, Fredy Suter, Sara Baruzzo, Vincenza Perani, Fausto Moioli, Giuseppe Remuzzi

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia'. Together they form a unique fingerprint.

Medicine & Life Sciences